Eucope Visual

Archives for News

OTCs & health claims: EFSA publishes draft Art.13-list

Monday, January 12th, 2009 in News

In January the European Food Safety Authority (EFSA) has published the draft health claims list. The consolidated list contains 4,185 claims. In line with Article 13 of the Regulation on nutrition and health claims made on foods (EC No. 1924/2006) EFSA will evaluate these claims in the next months and ... read more...

ECJ: Opinion on foreign ownership of pharmacies

Tuesday, December 16th, 2008 in News

On December 16th, 2008 Advocate General Yves Bot delivered his opinions in two cases relating to the rules governing the ownership of pharmacies. In joined Cases C-171/01 and C-172/07 (Apothekerkammer des Saarlandes and Others) the Advocate General takes the view that restrictions on foreign ownership of pharmacies do not breach ... read more...

Pharmaceutical Package

Monday, December 1st, 2008 in News

On December 10th, 2008 the European Commission presented several legislative proposals. Due to divergent views of some Commissioners, the Commission proposals regarding counterfeit medicines, information to patients and pharmacovigilance had been postponed several times. The proposal concerning counterfeit medicines (COM (2008) 668) introduces a mandatory safety feature for every package containing ... read more...

Sector inquiry: Preliminary report

Friday, November 28th, 2008 in News

On November 28th, 2008 the European Commission published its preliminary report on the competition inquiry into the pharmaceutical sector. The report finds that competition in the relation of originators towards generic companies as well as amongst originator companies themselves does not work as it should. According to the preliminary findings ... read more...

Parallel trade: judgement on contingency schemes

Tuesday, September 16th, 2008 in News

On September 16th, 2008 the European Court of Justice handed down its judgement in joined cases C-468-478/06 (Glaxo Greece - Syfait II). The ECJ holds that a dominant pharmaceutical undertaking which, in order to put a stop to parallel exports, refuses to meet the ordinary orders of wholesalers in general ... read more...